Please enable JavaScript to continue using this application.

Compare $IQV vs $WST | Chartloom

Compare

$IQV vs $WST

IQVIA Holdings Inc · West Pharmaceutical Services Inc

IQV

IQVIA Holdings Inc

WST

West Pharmaceutical Services Inc

Compare $IQV vs $WST

Comparing IQVIA Holdings Inc and West Pharmaceutical Services Inc

IQVIQVIA Holdings Inc

WSTWest Pharmaceutical Services Inc

IQVIQVIA Holdings Inc

Market cap

$42.78B

P/E (TTM)

31.62x

Forward P/E (NTM)

18.84x

Forward P/S (NTM)

2.36x

Rev growth (TTM)

8.2%

YTD performance

15.3%

52W performance

29.6%

FCF yield

5.1%

WSTWest Pharmaceutical Services Inc

Market cap

$25.76B

P/E (TTM)

46.20x

Forward P/E (NTM)

39.00x

Forward P/S (NTM)

7.45x

Rev growth (TTM)

12.4%

YTD performance

32.4%

52W performance

36.6%

FCF yield

1.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

IQV

WST

Detailed metrics comparison

IQV

IQVIA Holdings Inc

WST

West Pharmaceutical Services Inc

Market Cap

IQV$42.78B

WST$25.76B

Enterprise Value

IQV$56.87B

WST$25.53B

Price

IQV$259.88

WST$366.00

P/E Ratio

IQV31.62x

WST46.20x

P/S Ratio

IQV2.52x

WST7.74x

EV/Sales

IQV3.35x

WST7.67x

EV/EBITDA

IQV15.88x

WST28.16x

P/B Ratio

IQV6.89x

WST8.84x

P/FCF Ratio

IQV19.59x

WST58.96x

EV/FCF

IQV26.04x

WST58.44x

PEG Ratio

IQV1.93x

WST3.05x

Forward P/E (NTM)

IQV18.84x

WST39.00x

Forward P/S (NTM)

IQV2.36x

WST7.45x

Revenue (TTM)

IQV$16.98B

WST$3.33B

Revenue Growth (YoY)

IQV8.2%

WST12.4%

Forward Rev Growth

IQV6.0%

WST6.2%

Gross Margin (TTM)

IQV33.0%

WST36.8%

Operating Margin (TTM)

IQV12.9%

WST20.4%

EBITDA Margin (TTM)

IQV20.9%

WST27.0%

Net Margin (TTM)

IQV8.1%

WST17.0%

FCF Margin (TTM)

IQV12.9%

WST13.1%

Net Income (TTM)

IQV$1.38B

WST$565M

FCF (TTM)

IQV$2.18B

WST$437M

EPS (TTM)

IQV$8.22

WST$7.92

ROE (TTM)

IQV21.9%

WST18.5%

ROA (TTM)

IQV4.7%

WST13.6%

ROIC (TTM)

IQV6.3%

WST17.3%

Cash

IQV$1.91B

WST$436M

Debt

IQV$16.00B

WST$207M

Net Cash/Debt

IQV$-14.09B

WST$229M

Current Ratio (TTM)

IQV0.71x

WST2.82x

Quick Ratio (TTM)

IQV0.68x

WST2.12x

Debt/Equity (TTM)

IQV2.59x

WST0.07x

Debt/Assets (TTM)

IQV0.0%

WST0.0%

Interest Coverage (TTM)

IQVN/A

WSTN/A

Net Debt/EBITDA (TTM)

IQV0.00x

WST0.00x

Beta

IQV1.18

WST1.15

52W Performance

IQV29.6%

WST36.6%

YTD Performance

IQV15.3%

WST32.4%

% from 52W High

IQV-6.3%

WST-5.2%

% from 52W Low

IQV68.2%

WST63.5%

Asset Turnover (TTM)

IQV0.57x

WST0.80x

FCF Yield (TTM)

IQV5.1%

WST1.7%

Earnings Yield (TTM)

IQV3.2%

WST2.2%

Dividend Yield (TTM)

IQVN/A

WST0.2%

Rule of 40

IQV21.0

WST25.5

EV/GP/RG

IQV1.53

WST5.32

Ticker research

View IQV research View WST research

Metric	IQV IQVIA Holdings Inc	WST West Pharmaceutical Services Inc
Market & Valuation
Market Cap	$42.78B	$25.76B
Enterprise Value	$56.87B	$25.53B
Price	$259.88	$366.00
P/E Ratio	31.62x	46.20x
P/S Ratio	2.52x	7.74x
EV/Sales	3.35x	7.67x
EV/EBITDA	15.88x	28.16x
P/B Ratio	6.89x	8.84x
P/FCF Ratio	19.59x	58.96x
EV/FCF	26.04x	58.44x
PEG Ratio	1.93x	3.05x
Forward P/E (NTM)	18.84x	39.00x
Forward P/S (NTM)	2.36x	7.45x
Revenue & Growth
Revenue (TTM)	$16.98B	$3.33B
Revenue Growth (YoY)	8.2%	12.4%
Forward Rev Growth	6.0%	6.2%
Profitability
Gross Margin (TTM)	33.0%	36.8%
Operating Margin (TTM)	12.9%	20.4%
EBITDA Margin (TTM)	20.9%	27.0%
Net Margin (TTM)	8.1%	17.0%
FCF Margin (TTM)	12.9%	13.1%
Net Income (TTM)	$1.38B	$565M
FCF (TTM)	$2.18B	$437M
EPS (TTM)	$8.22	$7.92
ROE (TTM)	21.9%	18.5%
ROA (TTM)	4.7%	13.6%
ROIC (TTM)	6.3%	17.3%
Financial Health
Cash	$1.91B	$436M
Debt	$16.00B	$207M
Net Cash/Debt	$-14.09B	$229M
Current Ratio (TTM)	0.71x	2.82x
Quick Ratio (TTM)	0.68x	2.12x
Debt/Equity (TTM)	2.59x	0.07x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.18	1.15
52W Performance	29.6%	36.6%
YTD Performance	15.3%	32.4%
% from 52W High	-6.3%	-5.2%
% from 52W Low	68.2%	63.5%
Efficiency & Yields
Asset Turnover (TTM)	0.57x	0.80x
FCF Yield (TTM)	5.1%	1.7%
Earnings Yield (TTM)	3.2%	2.2%
Dividend Yield (TTM)	N/A	0.2%
Other
Rule of 40	21.0	25.5
EV/GP/RG	1.53	5.32
Ticker research	View IQV research	View WST research

Valuation

P/E Ratio

IQV

31.62x

WST

46.20x

P/S Ratio

IQV

2.52x

WST

7.74x

EV/FCF

IQV

26.04x

WST

58.44x

Growth & revenue

Revenue Growth TTM

WST

12.4%

IQV

8.2%

Forward Revenue Growth

WST

6.2%

IQV

6.0%

Profitability & performance

Gross Margin

WST

36.8%

IQV

33.0%

ROE

IQV

21.9%

WST

18.5%

FCF Yield %

IQV

5.1%

WST

1.7%

52-Week Performance

WST

36.6%

IQV

29.6%

Detailed metrics comparison

IQV

IQVIA Holdings Inc

WST

West Pharmaceutical Services Inc

Market Cap

IQV$42.78B

WST$25.76B

Enterprise Value

IQV$56.87B

WST$25.53B

Price

IQV$259.88

WST$366.00

P/E Ratio

IQV31.62x

WST46.20x

P/S Ratio

IQV2.52x

WST7.74x

EV/Sales

IQV3.35x

WST7.67x

EV/EBITDA

IQV15.88x

WST28.16x

P/B Ratio

IQV6.89x

WST8.84x

P/FCF Ratio

IQV19.59x

WST58.96x

EV/FCF

IQV26.04x

WST58.44x

PEG Ratio

IQV1.93x

WST3.05x

Forward P/E (NTM)

IQV18.84x

WST39.00x

Forward P/S (NTM)

IQV2.36x

WST7.45x

Revenue (TTM)

IQV$16.98B

WST$3.33B

Revenue Growth (YoY)

IQV8.2%

WST12.4%

Forward Rev Growth

IQV6.0%

WST6.2%

Gross Margin (TTM)

IQV33.0%

WST36.8%

Operating Margin (TTM)

IQV12.9%

WST20.4%

EBITDA Margin (TTM)

IQV20.9%

WST27.0%

Net Margin (TTM)

IQV8.1%

WST17.0%

FCF Margin (TTM)

IQV12.9%

WST13.1%

Net Income (TTM)

IQV$1.38B

WST$565M

FCF (TTM)

IQV$2.18B

WST$437M

EPS (TTM)

IQV$8.22

WST$7.92

ROE (TTM)

IQV21.9%

WST18.5%

ROA (TTM)

IQV4.7%

WST13.6%

ROIC (TTM)

IQV6.3%

WST17.3%

Cash

IQV$1.91B

WST$436M

Debt

IQV$16.00B

WST$207M

Net Cash/Debt

IQV$-14.09B

WST$229M

Current Ratio (TTM)

IQV0.71x

WST2.82x

Quick Ratio (TTM)

IQV0.68x

WST2.12x

Debt/Equity (TTM)

IQV2.59x

WST0.07x

Debt/Assets (TTM)

IQV0.0%

WST0.0%

Interest Coverage (TTM)

IQVN/A

WSTN/A

Net Debt/EBITDA (TTM)

IQV0.00x

WST0.00x

Beta

IQV1.18

WST1.15

52W Performance

IQV29.6%

WST36.6%

YTD Performance

IQV15.3%

WST32.4%

% from 52W High

IQV-6.3%

WST-5.2%

% from 52W Low

IQV68.2%

WST63.5%

Asset Turnover (TTM)

IQV0.57x

WST0.80x

FCF Yield (TTM)

IQV5.1%

WST1.7%

Earnings Yield (TTM)

IQV3.2%

WST2.2%

Dividend Yield (TTM)

IQVN/A

WST0.2%

Rule of 40

IQV21.0

WST25.5

EV/GP/RG

IQV1.53

WST5.32

Ticker research

View IQV research View WST research

Metric	IQV IQVIA Holdings Inc	WST West Pharmaceutical Services Inc
Market & Valuation
Market Cap	$42.78B	$25.76B
Enterprise Value	$56.87B	$25.53B
Price	$259.88	$366.00
P/E Ratio	31.62x	46.20x
P/S Ratio	2.52x	7.74x
EV/Sales	3.35x	7.67x
EV/EBITDA	15.88x	28.16x
P/B Ratio	6.89x	8.84x
P/FCF Ratio	19.59x	58.96x
EV/FCF	26.04x	58.44x
PEG Ratio	1.93x	3.05x
Forward P/E (NTM)	18.84x	39.00x
Forward P/S (NTM)	2.36x	7.45x
Revenue & Growth
Revenue (TTM)	$16.98B	$3.33B
Revenue Growth (YoY)	8.2%	12.4%
Forward Rev Growth	6.0%	6.2%
Profitability
Gross Margin (TTM)	33.0%	36.8%
Operating Margin (TTM)	12.9%	20.4%
EBITDA Margin (TTM)	20.9%	27.0%
Net Margin (TTM)	8.1%	17.0%
FCF Margin (TTM)	12.9%	13.1%
Net Income (TTM)	$1.38B	$565M
FCF (TTM)	$2.18B	$437M
EPS (TTM)	$8.22	$7.92
ROE (TTM)	21.9%	18.5%
ROA (TTM)	4.7%	13.6%
ROIC (TTM)	6.3%	17.3%
Financial Health
Cash	$1.91B	$436M
Debt	$16.00B	$207M
Net Cash/Debt	$-14.09B	$229M
Current Ratio (TTM)	0.71x	2.82x
Quick Ratio (TTM)	0.68x	2.12x
Debt/Equity (TTM)	2.59x	0.07x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.18	1.15
52W Performance	29.6%	36.6%
YTD Performance	15.3%	32.4%
% from 52W High	-6.3%	-5.2%
% from 52W Low	68.2%	63.5%
Efficiency & Yields
Asset Turnover (TTM)	0.57x	0.80x
FCF Yield (TTM)	5.1%	1.7%
Earnings Yield (TTM)	3.2%	2.2%
Dividend Yield (TTM)	N/A	0.2%
Other
Rule of 40	21.0	25.5
EV/GP/RG	1.53	5.32
Ticker research	View IQV research	View WST research